EVI Lianidou

About EVI Lianidou

EVI Lianidou, With an exceptional h-index of 59 and a recent h-index of 41 (since 2020), a distinguished researcher at National and Kapodistrian University of Athens, specializes in the field of Liquid Biopsy, Circulating Tumor Cells, ctDNA, molecular diagnostics, Clinical Chemistry.

His recent articles reflect a diverse array of research interests and contributions to the field:

Multiplex detection of ten ESR1 mutations and AKT1 E17K in breast cancer using digital PCR

MCT1 and ΜCT4 on circulating tumor cells isolated from non small cell lung cancer patients

Detection of hotspot PIK3CA mutations in primary tumors and plasma-cfDNA of breast cancer patients using a novel highly sensitive CE-IVD kit

Detection of PD-L1 mRNA expression in circulating tumor cells (CTCs) from patients with metastatic NSCLC, HNSCC and melanoma using a novel highly sensitive …

Liquid biopsy for the management of NSCLC patients under osimertinib treatment

Pre-analytical conditions and implementation of quality control steps in liquid biopsy analysis

Development and Validation of a Novel Dual-Drop-off ddPCR Assay for the Simultaneous Detection of Ten Hotspots PIK3CA Mutations

Phase II window study of olaparib alone or with cisplatin or durvalumab in operable Head and Neck Cancer

EVI Lianidou Information

University

Position

___

Citations(all)

11042

Citations(since 2020)

4692

Cited By

8187

hIndex(all)

59

hIndex(since 2020)

41

i10Index(all)

141

i10Index(since 2020)

104

Email

University Profile Page

Google Scholar

EVI Lianidou Skills & Research Interests

Liquid Biopsy

Circulating Tumor Cells

ctDNA

molecular diagnostics

Clinical Chemistry

Top articles of EVI Lianidou

Multiplex detection of ten ESR1 mutations and AKT1 E17K in breast cancer using digital PCR

The Journal of Liquid Biopsy

2024/9/1

Evi Lianidou
Evi Lianidou

H-Index: 41

MCT1 and ΜCT4 on circulating tumor cells isolated from non small cell lung cancer patients

Cancer Research

2024/3/22

Evi Lianidou
Evi Lianidou

H-Index: 41

Detection of hotspot PIK3CA mutations in primary tumors and plasma-cfDNA of breast cancer patients using a novel highly sensitive CE-IVD kit

Cancer Research

2024/3/22

Detection of PD-L1 mRNA expression in circulating tumor cells (CTCs) from patients with metastatic NSCLC, HNSCC and melanoma using a novel highly sensitive …

Cancer Research

2024/3/22

Liquid biopsy for the management of NSCLC patients under osimertinib treatment

2024/2/1

Evi Lianidou
Evi Lianidou

H-Index: 41

Pre-analytical conditions and implementation of quality control steps in liquid biopsy analysis

2023/11/17

Evi Lianidou
Evi Lianidou

H-Index: 41

Development and Validation of a Novel Dual-Drop-off ddPCR Assay for the Simultaneous Detection of Ten Hotspots PIK3CA Mutations

Analytical Chemistry

2023/9/8

Evi Lianidou
Evi Lianidou

H-Index: 41

Phase II window study of olaparib alone or with cisplatin or durvalumab in operable Head and Neck Cancer

Cancer Research Communications

2023/8/10

Development and Validation of Molecular Assays for Liquid Biopsy Applications

2020/1/7

Circulating Tumor Cells: Advances in Liquid Biopsy Technologies

2023/8/1

Evi Lianidou
Evi Lianidou

H-Index: 41

Highly Sensitive Detection Method of CXCR4 Tumor Hotspot Mutations by Drop-Off Droplet Digital PCR in Patients with IgM Monoclonal Gammopathies

The Journal of Molecular Diagnostics

2023/7/1

Clinical Significance of PD-L1 Status in Circulating Tumor Cells for Cancer Management during Immunotherapy

2023/6/20

Evi Lianidou
Evi Lianidou

H-Index: 41

Amanda Psyrri
Amanda Psyrri

H-Index: 38

Development and Analytical Validation of a 6-Plex Reverse Transcription Droplet Digital PCR Assay for the Absolute Quantification of Prostate Cancer Biomarkers in Circulating …

Clinical Chemistry

2022/10/4

Martha Zavridou
Martha Zavridou

H-Index: 7

Evi Lianidou
Evi Lianidou

H-Index: 41

Detection and molecular characterization of circulating tumour cells: challenges for the clinical setting

2023/4/6

Evi Lianidou
Evi Lianidou

H-Index: 41

6-color Crystal Digital PCR for the high-plex detection of 10 ESR1 mutations in breast cancer

Cancer Research

2023/4/4

Evi Lianidou
Evi Lianidou

H-Index: 41

Preoperative Mutational Analysis of Circulating Tumor Cells (CTCs) and Plasma-cfDNA Provides Complementary Information for Early Prediction of Relapse: A Pilot Study in Early …

Cancers

2023/3/21

Comprehensive liquid biopsy analysis as a tool for the early detection of minimal residual disease in breast cancer

Scientific Reports

2023/1/23

Martha Zavridou
Martha Zavridou

H-Index: 7

Evi Lianidou
Evi Lianidou

H-Index: 41

Delta SARS-CoV-2 variant is entirely substituted by the omicron variant during the fifth COVID-19 wave in Attica region

Science of The Total Environment

2023/1/15

Purpose: Monocarboxylate transporter 4 (MCT4) can influence the amount of lactate in the tumor microenvironment and further control cancer cell proliferation, migration, and …

Liquid Biopsy

2022/11/8

Liquid biopsy analysis as a tool for TKI-Based treatment in non-small cell lung cancer

2022/9/14

Michał Nowicki
Michał Nowicki

H-Index: 10

Evi Lianidou
Evi Lianidou

H-Index: 41

See List of Professors in EVI Lianidou University(National and Kapodistrian University of Athens)

Co-Authors

academic-engine